VeenaSusanJohnMD

Oncology • New Hyde Park, NY

Breast Cancer, Gynecologic Cancer, Hematologic Oncology

Assistant Professor, Medicine, Hofstra North Shore-LIJ

Join to view full profile

Dr. John is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. John's full profile

Already have an account?

Office
450 Lakeville Rd
North Shore University Hosp.
New Hyde Park, NY 11042
Is this information wrong?

Education & Training

North Shore-Long Island Jewish Health SystemFellowship, Hematology/Oncology, 1999 - 2002
Flushing Hospital Medical CenterResidency, Internal Medicine, 1996 - 1999
Christian Medical College LudhianaClass of 1992

Certifications & Licensure

NY State Medical License 1999 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Chief Fellow NSUH, 2002
Best Consultant NY Flushing Hospital, 1999
Dr Bir Inder Kumar Chatley First Prize for Social and Preventive Medicine during Internship Christian Medical College, 1992

Clinical Trials

Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 01Pisani, A.L.,Burnett, A.F.,Guirguis, A.S.,Brockmeyer, A.D.,Green, A.E.,Kueck, A.S.,Kamat, A.A.,Edraki, B.,Marchello, B.T.,Rimel, B.J.,Johnston, C.M.,Holschneider, C.H.,Cathcart, C.K.,Chase, D.M.,Alberts, ...
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial Start of enrollment: 2012 Jan 01Benjamin, I.,Mannel, R.S.,Moore, K.N.,Morgan, R.E.,Scribner, D.R.,Thigpen, J.T.
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary Start of enrollment: 2009 Aug 01Abbas, F.M.,Abulafia, O.,Anderson, D.M.,Behrens, R.J.,Benjamin, I.,Boothby, R.A.,Borowsky, M.E.,Bosscher, J.R.,Boulay, R.M.,Buekers, T.E.,Bury, M.J.,Carolla, R.L.,Cha, S.,Chambers, S.K.,Cloven, N.G.,Colli...
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma Start of enrollment: 2009 Jun 01Abbas, F.M.,Abulafia, O.,Anderson, D.M.,Atkins, J.N.,Bae, D.,Behrens, R.J.,Benjamin, I.,Berman, M.L.,Blank, S.V.,Boothby, R.A.,Borowsky, M.E.,Boulay, R.M.,Bristow, R.E.,Buckley, S.L.,Buekers, T.E.,Burke, ...
A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, In Stage IVB, Recurrent or Start of enrollment: 2009 Apr 01Abbas, F.M.,Abulafia, O.,Agarwala, S.S.,Anderson, M.L.,Atkins, J.N.,Basil, J.,Behrens, R.J.,Bell, M.C.,Benjamin, I.,Berman, M.L.,Blank, S.V.,Boothby, R.A.,Borowsky, M.E.,Boulay, R.M.,Bristow, R.E.,Buekers...
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma Start of enrollment: 2009 Mar 01Abbas, F.M.,Abulafia, O.,Arango, H.A.,Basil, J.,Behrens, R.J.,Benjamin, I.,Berman, M.L.,Borowsky, M.E.,Bristow, R.E.,Brockmeyer, A.D.,Buekers, T.E.,Burke, W.M.,Carney, M.E.,Carolla, R.L.,Cass, I.,Chamberl...
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus Start of enrollment: 2008 Feb 01Abulafia, O.,Anderson, P.,Atkins, J.N.,Barkati, M.,Basil, J.,Behrens, R.J.,Borowsky, M.E.,Cardenes, H.R.,Carolla, R.L.,Chamberlain, D.H.,Clarkson, J.E.,Collins, Y.C.,Constantinou, C.L.,Flynn, P.J.,Fort, G...
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritone Start of enrollment: 2007 Dec 01Abulafia, O.,Armstrong, D.K.,Bae, D.,Behrens, R.J.,Blank, S.V.,Borowsky, M.E.,Boulay, R.M.,Bury, M.J.,Carolla, R.L.,Cho, C.,Choksi, J.K.,Clarkson, J.E.,Coleman, R.L.,Dakhil, S.R.,Dinh, T.A.,Downey, G.O.,E...
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal or Fallopia Start of enrollment: 2005 Mar 01Abu-Ghazaleh, S.Z.,Abulafia, O.,Arango, H.A.,Behrens, R.J.,Borowsky, M.E.,Bristow, R.E.,Buekers, T.E.,Burger, R.A.,Bury, M.J.,Carolla, R.L.,Cass, I.,Chamberlain, D.H.,Choksi, J.K.,Clarkson, J.E.,Dakhil, S...
Join now to see all

Publications & Presentations

PubMed

Trastuzumab-DM1: a clinical update of the novel antibody-drug conjugate for HER2-overexpressing breast cancer.
Myra F. Barginear, Veena S. John, Daniel R. Budman> ;Molecular Medicine. 2012 Nov 1

Journal Articles

Metastatic Malignant Ovarian Steroid Cell Tumor:A Case Report and Review of the Literature
Jessica Lee,1 Veena S. John,2 Sharon X. Liang,3Catherine A. D’Agostino,4 and AndrewW.Menzin5, Case Reports in Obstetrics and Gynecology, 6/2016
Correlative In-vitro Chemotherapy Drug Resistance Assay to Clinical Response to Platinum and Taxane Chemotherapy in Ovarian Carcinoma
Kit L Cheng, Iuliana Shapira, Lisa Rosen, Veena John, John Lovecchio, Andrew Menzin, Jill Whyte, Lisa Dos Santos, Diana Contreras, Antoinette Sakaris, Karin Shih, Raja..., J Clin Oncol, 1/1/2013
Percutaneous Insertion of Peritoneal Ports
Greben, Craig R. MD; Goldstein, Greg E. MD; Lovecchio, John MD; John, Veena MD; Putterman, Daniel MD; Caplin, Drew MD; Gandras, Eric J. MD, International Journal of Gynecological Cancer, 2/1/2012
The Histone Deacetylase Inhibitor Panobinostat Demonstrates Marked Synergy with Conventional Chemotherapeutic Agents in Human Ovarian Cancer Cell Lines
Budman DR, Tai J, Calabro A, John V, Invest New Drugs, 12/1/2011
Disparities in Referral by Risk Profile for Genetic Counseling of High-risk Individuals: A Disease-specific Analysis of Mutation Frequencies of 1,193 Patients Presenti...
I. Shapira, R. J. Gralla, K. S. Sultan, V. S. John, C. E. Devoe, J. T. D'Olimpio, H. Raftopoulos, L. Donahue, V. Vinciguerra, S. Cohen, J Clin Oncol, 1/1/2010
Prevention of Mucositis in AutoBMT/stem Cell Transplant Patients
Klocke J, Cannon M, Devoe C, Gissinger D, John V, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2006
Hyperparathyroidism Accompanying Multiple Myeloma
Patel N, Talwar A, Donahue L, John V, Margouleff D, Clin Nucl Med, 8/1/2005
Human Herpesvirus 6 Manifesting as Encephalitis in Hematopoietic Progenitor Cell Recipient after Reduced Intensity Allogeneic Transplantation
Ng N, Devoe C, John V, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2005
Safety of Bisphosphonate Use in Hematopoietic Progenitor Cell Transplantation in Multiple Myeloma Patients
Mazj S, Ng N, Lichtman SM, John V, Devoe C, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2005
Complex Translocation (8;16;21): A New Variant of t(8;21) With t(13;22) In Acute Myeloid Leukemia
Gupta S, Brody J, John V, Koduru P, Am. Soc Hematol Mtg. Blood, 1/1/2005
Clinical Evaluation of the Adverse Effects of Voriconazole in the Management of Hemopoeitic Stem Cell Transplant Patients
Li H, Mazj S, John V, Focazio B, Devoe C, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2004
Role of Low-dose Heparin, Ursodiol and Glutamine in Preventing Veno-occlussive Disease of the Liver in Adults Undergoing Hematopoietic Stem Cell Ransplantation
Desai MR, McCreary EL, Focazio B, Devoe C, John VS, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2004
Allografting with Fludarabine and ATG after Failed Engraftment of Autologous Peripheral Blood Stem Cells
Bayer R, Focazio B, John V, Loscalzo J, Buchbinder A, Biology of Blood and Marrow Transplantation, 2/1/2003
Parameters for Optimal Timing for Hematopoietic Progenitor Cell Collection
Kok B, John VS, Loscalzo J, Malavade V, Buchbinder A, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2003
Safety of Rituximab following Autologous Stem Cell Transplant
Calderon N, John VS, Loscalzo J, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2003
Harmacological Factors Influencing Anticancer Drug Selection in the Elderly
Veena John; Sandeep Mashru; Stuart M Lichtman, Drugs & Aging, 1/1/2003
Join now to see all

Abstracts/Posters

Circulating microRNA Patterns in Ovarian Cancer Increased Expression with Surgical Intervention and Chemotherapy: Stable High Presurgical "survival Pattern" (SP) miRNA...
Iuliana Shapira, Annette Lee, Mary Keogh, Cathleen Mason, Michaela Oswald, John Lovecchio, Sharon Liang, Jill Whyte, Tawfiqul Bhuiya, Kit Cheng, Sabeen Mekan, Karen Gl..., Cancer Research, AACR 103rd Annual Meeting, Chicago, 4/15/2012
Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis
Budman, Meredith Akerman, Lora Weiselberg, Vincent Vinciguerra, James D'Olimpio, Craig Devoe, Kit Ling Cheng, Laura Donahue, Veena John, Sharona Cohen, Cancer Research, Thirty-Fourth Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, 12/15/2011
Kepivance Use in Allogeneic Stem Cell Transplantation
Bayer, R.-L., Kim, B., John, V., Devoe, C., Cannon, M., Klocke, J., Gissinger, Biology of Blood and Marrow Transplantation, D. North Shore University Hospital, Manhasset, NY, 2/1/2007

Other

"Paclitaxel/Carboplatin with or without Sorafenib in the First-Line Treatment of Patients with Stage III/IV Epithelial Ovarian Cancer: A Randomized Phase II Study of t...

Press Mentions

Statins Tied to Significantly Lower Death Rate from Ovarian CancerJune 25, 2020 09:42
Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian CancerOctober 29, 2019 21:33